Dr. Diehl on the Unique Nature of Hodgkin's Lymphoma

Volker Diehl, MD
Published: Tuesday, Nov 08, 2011

Volker Diehl, MD, Professor of Medicine, Emeritus, University of Cologne, Germany, explains that Hodgkin's lymphoma is unique because the microenvironment contains a minority of tumors cells and an abundance of reactive cells.

This disease demonstrates an intelligent interaction between the microenvironment and the tumor cells. When treating Hodgkin's lymphoma is it necessary to kill all cells including the inert tumor cells and the not yet well-defined clonogenic cells that interact with the microenvironment.

Volker Diehl, MD, Professor of Medicine, Emeritus, University of Cologne, Germany, explains that Hodgkin's lymphoma is unique because the microenvironment contains a minority of tumors cells and an abundance of reactive cells.

This disease demonstrates an intelligent interaction between the microenvironment and the tumor cells. When treating Hodgkin's lymphoma is it necessary to kill all cells including the inert tumor cells and the not yet well-defined clonogenic cells that interact with the microenvironment.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Moving Forward From the Status Quo for the Treatment of Soft Tissue Sarcoma: Key Questions and New Answers to Optimize OutcomesOct 31, 20182.0
Hematology Briefings™: Advancing Care and Improving Outcomes for Patients With Pyruvate Kinase DeficiencyOct 31, 20181.0
Publication Bottom Border
Border Publication
x